SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; Veterans Affairs Palo Alto Healthcare System and Stanford University School of Medicine (affiliate), Palo Alto, California; Division of Gastroenterology, McGill University, Montreal, Quebec, Canada; University of California at San Francisco, Veterans Affairs Medical Center, San Francisco, California; University of Leeds, Leeds, United Kingdom

[1]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[2]  Romina Brignardello-Petersen,et al.  Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise , 2014, Canadian Medical Association Journal.

[3]  R. Soetikno,et al.  Dynamic submucosal injection technique. , 2010, Gastrointestinal endoscopy clinics of North America.

[4]  K. Matsuda,et al.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population , 2003, British Journal of Cancer.

[5]  J. Goldblum,et al.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.

[6]  Bernhard Nafe,et al.  Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2003, Gastroenterology.

[7]  D. Present,et al.  Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. , 2005, Inflammatory bowel diseases.

[8]  N. Harpaz,et al.  Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  N. Suzuki,et al.  Narrow Band Imaging for Detection of Dysplasia in Colitis: A Randomized Controlled Trial , 2012, The American Journal of Gastroenterology.

[10]  A. Forbes,et al.  Most dysplasia in ulcerative colitis is visible at colonoscopy. , 2004, Gastrointestinal endoscopy.

[11]  M. Kamm,et al.  Chromoendoscopy versus Narrow Band Imaging for Colonic Surveillance in Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[12]  M. Iida,et al.  Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis , 2003, American Journal of Gastroenterology.

[13]  E. Dekker,et al.  Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  S. Kudo,et al.  Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. , 2008, Inflammatory bowel diseases.

[15]  Laurent Beaugerie,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. , 2013, Journal of Crohn's & colitis.

[16]  S. Vermeire,et al.  506 Chromo-Endoscopy Versus Narrow Band Imaging in Ulcerative Colitis: A Prospective Randomized Controlled Trial , 2012 .

[17]  D. Hommes,et al.  Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. , 2007, Endoscopy.

[18]  A. Price,et al.  Observer variation in the assessment of dysplasia in ulcerative colitis , 1988, Histopathology.

[19]  R. Soetikno,et al.  An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. , 2014, Gastrointestinal endoscopy clinics of North America.

[20]  J. Crook,et al.  Procedure Time and the Determination of Polypoid Abnormalities with Experience: Implementation of a Chromoendoscopy Program for Surveillance Colonoscopy for Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[21]  C. Lightdale,et al.  Nonpolypoid colorectal neoplasms in inflammatory bowel disease , 2014 .

[22]  U. Navaneethan,et al.  Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. , 2013, Journal of Crohn's & colitis.

[23]  D. Knol,et al.  Tracking the Molecular Features of Nonpolypoid Colorectal Neoplasms: A Systematic Review and Meta‐Analysis , 2013 .

[24]  E. Dekker,et al.  Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions , 2008, Gut.

[25]  M. Laurant,et al.  Factors associated with the impact of quality improvement collaboratives in mental healthcare: An exploratory study , 2012, Implementation Science.

[26]  E. Dekker,et al.  Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis , 2010, Endoscopy.

[27]  C. Hawkey,et al.  Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesions During Surveillance Colonoscopy in Patients with Colonic Inflammatory Bowel Disease , 2011, Inflammatory bowel diseases.

[28]  R. Kiesslich,et al.  Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. , 2004, Endoscopy.

[29]  Frank Heller,et al.  Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols , 2011, International Journal of Colorectal Disease.

[30]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[31]  M. Bronner,et al.  Progression of Flat Low-Grade Dysplasia to Advanced Neoplasia in Patients with Ulcerative Colitis , 2004 .

[32]  Krish Ragunath,et al.  Advanced endoscopic imaging: a review of commercially available technologies. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  A. Forbes,et al.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis , 2004, Gut.

[34]  R. Steele,et al.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.

[35]  S. Kakar,et al.  The fate of low grade dysplasia in ulcerative colitis , 2002, American Journal of Gastroenterology.

[36]  N. Suzuki,et al.  Endoscopic management of nonpolypoid colorectal lesions in colonic IBD. , 2014, Gastrointestinal endoscopy clinics of North America.

[37]  J. Marion,et al.  Surveillance in inflammatory bowel disease: chromoendoscopy and digital mucosal enhancement. , 2013, Gastrointestinal endoscopy clinics of North America.

[38]  J. Llach,et al.  Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. , 2011, Gastrointestinal endoscopy.

[39]  A. Forbes,et al.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.

[40]  R. Pollok,et al.  Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection , 2016, Digestive Diseases and Sciences.

[41]  D. Rubin,et al.  Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? , 2007, Gastrointestinal endoscopy.

[42]  R. McLeod,et al.  Position Statement on the Diagnosis and Management of olorectal Neoplasia in Inflammatory Bowel Disease , 2022 .

[43]  R. Kiesslich,et al.  Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. , 2007, Gastroenterology.

[44]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[45]  N. Soehendra,et al.  Endoscopic mucosal resection. , 2003, Endoscopy.

[46]  N. Harpaz,et al.  Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial , 2008, The American Journal of Gastroenterology.

[47]  T. Hlavatý,et al.  Colorectal cancer screening in patients with ulcerative and crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy , 2011, European journal of gastroenterology & hepatology.

[48]  K. Mcquaid,et al.  Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must. , 2014, Gastrointestinal endoscopy clinics of North America.

[49]  D. Rubin,et al.  Outcome after surveillance of low‐grade and indefinite dysplasia in patients with ulcerative colitis , 2010, Inflammatory bowel diseases.

[50]  P. Shekelle,et al.  Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations , 2012, Implementation Science.

[51]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[52]  E. Dekker,et al.  Random Biopsies Taken During Colonoscopic Surveillance of Patients With Longstanding Ulcerative Colitis: Low Yield and Absence of Clinical Consequences , 2014, The American Journal of Gastroenterology.

[53]  J. Lewis,et al.  High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis , 2008, Scandinavian journal of gastroenterology.

[54]  R. Odze,et al.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[55]  N. Harpaz,et al.  Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. , 2011, Gastrointestinal endoscopy.

[56]  R. Odze,et al.  Aga Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease Learning Objectives Are Patients with Ibd at Increased Risk for Developing Crc? Uc , 2022 .

[57]  E. Loftus,et al.  Rate of Early/Missed Colorectal Cancers After Colonoscopy in Older Patients With or Without Inflammatory Bowel Disease in the United States , 2013, The American Journal of Gastroenterology.

[58]  C. Rubio,et al.  Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. , 1996, Gastrointestinal endoscopy.

[59]  J. Lewis,et al.  Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? , 2008, Scandinavian journal of gastroenterology.

[60]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[61]  A. Barkun,et al.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastroenterology.

[62]  R. Soetikno,et al.  The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. , 2013, Gastroenterology.

[63]  Lisa M. Schwartz,et al.  When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations , 2008, Inflammatory bowel diseases.

[64]  Yasushi Sano,et al.  American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. , 2008, Gastroenterology.

[65]  T. Thomas,et al.  Meta‐analysis: cancer risk of low‐grade dysplasia in chronic ulcerative colitis , 2007, Alimentary pharmacology & therapeutics.

[66]  J. Goldblum,et al.  Interobserver Variability in the Diagnosis of Ulcerative Colitis-Associated Dysplasia by Telepathology , 2002, Modern Pathology.

[67]  D. Hommes,et al.  Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia , 2013, Inflammatory bowel diseases.

[68]  K. Chayama,et al.  Non-polypoid colorectal neoplasms in ulcerative colitis. , 2010, Gastrointestinal endoscopy clinics of North America.

[69]  A. Zinsmeister,et al.  Outcome of Sporadic Adenomas and Adenoma‐Like Dysplasia in Patients with Ulcerative Colitis Undergoing Polypectomy§† , 2012, Inflammatory bowel diseases.

[70]  D. Faigel,et al.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. , 2006, Gastrointestinal endoscopy.